Consistent with these findings, FGF2 overexpression accelerated tumor growth, enhanced pulmonary metastasis, and decreased overall survival, which were reversed by ONECUT2 knockdown (Fig. 6E–J). This evidence concerns the gene ONECUT2 and neoplasm.